JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.00722-06v1
44/11/4227    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shames, R.
Right arrow Articles by Smith, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shames, R.
Right arrow Articles by Smith, M. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2006, p. 4227-4228, Vol. 44, No. 11
0095-1137/06/$08.00+0     doi:10.1128/JCM.00722-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Susceptibilities of Propionibacterium acnes Ophthalmic Isolates to Ertapenem, Meropenem, and Cefepime{triangledown}

Robert Shames,1 Farhana Satti,1 Ernestine M. Vellozzi,2 and Miriam A. Smith1*

Division of Infectious Disease,1 Division of Microbiology, Long Island Jewish Medical Center, Albert Einstein College of Medicine, New Hyde Park, New York 110422

Received 5 April 2006/ Returned for modification 26 June 2006/ Accepted 1 September 2006

We investigated the in vitro susceptibilities of 23 Propionibacterium acnes ophthalmic isolates to ertapenem, meropenem, and cefepime by utilizing the Etest. The MICs ranged from 0.094 µg/ml to 0.75 µg/ml, 0.094 µg/ml to 1.5 µg/ml, and 1 µg/ml to 12 µg/ml for ertapenem, meropenem, and cefepime, respectively. Based on our excellent in vitro carbapenem susceptibility results, in vivo studies using ertapenem and meropenem in a rabbit model of P. acnes endophthalmitis are warranted.

* Corresponding author. Mailing address: Long Island Jewish Medical Center, Division of Infectious Disease, Staff House Rm. 226, Lakeville Rd., New Hyde Park, NY 11042. Phone: (718) 470-7290. Fax: (718) 470-0637. E-mail: msmith{at}lij.edu.

{triangledown} Published ahead of print on 13 September 2006.

Journal of Clinical Microbiology, November 2006, p. 4227-4228, Vol. 44, No. 11
0095-1137/06/$08.00+0     doi:10.1128/JCM.00722-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.